MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >
ASH 2013 Presentations

Click the links below to download the ASH presentations.

Introduction – Stephen Nimer, MD

Prognostic Scoring System for Therapeutic Decision Making in MDS Patients – Peter Greenberg, MD

Novel Agents and Combinations for the Treatment of MDS – Pierre Fenaux, MD

Improving the Role of Flow Cytometry for the Characterization of MDS – Arjan van de Loosdrecht, MD, PhD

Marrow Microenvironmental Abnormalities in MDS – David Scadden, MD

Molecular Abnormalities and Their Impact on Prognosis of MDS Patients – Benjamin Ebert, MD, PhD

Review answers to commonly asked questions or get answers to your questions from an MDS expert